The Sprint Fidelis lead fracture story: What do we really know and where do we go from here?

Heart Rhythm

Volumn 5, Issue 10, 2008, Pages 1380-1381

  Ellenbogen, Kenneth A ^a   Wood, Mark A ^a   Swerdlow, Charles D ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFIBRILLATION; DEFIBRILLATOR; EDITORIAL; ELECTRIC SHOCK; HEART PACING; HUMAN; IMPEDANCE; LEAD FRACTURE; PATIENT CARE; PRIORITY JOURNAL; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

DEFIBRILLATORS, IMPLANTABLE; ELECTRIC IMPEDANCE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HUMANS;

EID: 54549099073     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.08.001     Document Type: Editorial

References (16)

1. Carlson M.D., Wilkoff B.L., Maisel W.H., et al. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines. Heart Rhythm 3 (2006) 1250-1273
2. Amin M., Matchar D.B., Wood M.A., et al. Management of recalled pacemakers and implantable cardioverter-defibrillators. A decision analysis model. JAMA 296 (2006) 412-420
3. Hayes D.L., Graham K.J., Irwin M., et al. Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 18 (1995) 999-1004
4. Lawton J.S., Wood M.A., Gilligan D.M., et al. Implantable transvenous cardioverter defibrillator leads: The dark side. Pacing Clin Electrophysiol 19 (1996) 1273-1278
5. Eckstein J., Koller M.T., Zabel M., et al. Necessity for surgical revision of defibrillator leads implanted long-term. Circulation 117 (2008) 2727-2733
6. Kennergren C. A European perspective on lead extraction: Part I. Heart Rhythm 5 (2008) 160-162
7. Hauser R.G., Kallinen L.M., Almquist A.K., et al. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 4 (2008) 892-896
8. ™ leads. Available from http://www.medtronic.com/fidelis/appendixC.html.
9. Medtronic Inc. Sprint Fidelis lead performance update. May 7, 2008.
10. Birnie D., Farwell D., Green M.S., et al. Accelerating risks of Fidelis lead fracture. Heart Rhythm 5 (2008) 1375-1379
11. Danik S.B., Mansour M., Singh J., et al. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm 4 (2007) 439-442
12. Krahn A.D., Champagne J., Healey J.S., et al. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Working Group on Device Advisories. Heart Rhythm 5 (2008) 639-642
13. Gunderson B.D., Patel A.S., Bounds C.S., et al. An algorithm to predict implantable cardioverter-defibrillator lead failure. J Am Coll Cardiol 44 (2004) 1898-1902
14. Ellenbogen K.A., Gunderson B.D., Ousdigian K.T., et al. Algorithm for early identification of Sprint Fidelis ICD Lead Fractures. Heart Rhythm 5 (2008) S33
15. Kallinen L.M., Hauser R.G., Lee K.W., et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 5 (2008) 775-779
16. Swerdlow C.D., Stadler R.W., Jackson T.E., et al. Inappropriate shocks due to Sprint Fidelis ICD lead fracture may be reduced by programming more intervals for detection of ventricular fibrillation. Heart Rhythm 5 (2008) S33